AJX

0.00%

1.1¢ alexium international group limited

Ann: Foundation for 2016, page-195

First 195 Last

Share
Profile

Follow
DigitInvestor

1,243 Posts.

31/08/16

06:51

Post #: 18809370
Share

Originally posted by susieq ↑

Hmm well maybe they would rather be conservative in their forecast now as they dont want to over promise and under deliver as they would have plenty of naysayers yelling doom and gloom if they fell a $1 short I am sure . Plus they would know more on sales etc than they did 8 months ago. Also the upside potential in that release was a potential upside we may even get more than 18 mill yet.

Yes maybe the company shouldnt of said that but there are plenty of companies who state their upside, so maybe their flaw has been too much positivity (not that I personally think positivity is a flaw). Personally for them to reiterate 18 mill must mean they will come pretty close to it for CY 16. Also good to realise that the revenue for CY15 was only 1,545,292 so if CY16 comes in as stated this equates to approx 1,179% increase in a year which is fantastic strong growth and that wont be huff,puff or fluff IMO. Remembering too this is really only their first full CY of sales.

Honestly if you are so negative on a company why would you consider buying at a lower price unless there are ulterior motives. Say if you purchased at a lower price will the business change after you have purchased or will it still be the same business as at todays prices? Also if you were to purchase at a lower price as you mentioned I presume you would expect the company shareprice to rise after you have purchased. So what pray tell do you think will increase the shareprice, will it be increasing revenue? Also once purchased at a supposedly lower price would you then think the company was a good one and not full of fluff?

Anyway who knows where the sp is heading and yes we may stagnate and sit here at these lows for a while, however if the companies revenue keeps growing then Id say Alexium IMO is a long way from running out of huff. Now this is why I am still invested but hey I am not right all of the time just 99% as my partner would say

All my view I am sure there will be plenty who disagree

Expand

Can I just add... Last year they were aiming for $10M plus... And they achieved less than 10% of this revenue?

And talk on here when it wasn't achieved was something along the lines of... It just takes a long time for receipts to come in... So I guess my question is... Is the money we are seeing the quarterlies from last year - finally coming in... Or more recent dollars?

If it is from last year... Does that mean that the $18.5M that is being targeted may not be seen until next year?

AJX Price at posting: 47.5¢ Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

There are more pages in this discussion • 13 more messages in this thread...

First 195 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $17.31M

Open	High	Low	Value	Volume
1.1¢	1.1¢	1.1¢	$3.3K	300K

Buyers (Bids)

No.	Vol.	Price($)
5	2072715	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	133	1

View Market Depth

No.	Vol.	Price($)
5	2072715	0.009
3	4111222	0.008
3	349012	0.007
3	544500	0.006
1	300000	0.005

Price($)	Vol.	No.
0.010	133	1
0.011	768054	5
0.013	240000	1
0.014	134311	1
0.015	431158	2

Last trade - 12.31pm 27/09/2024 (20 minute delay)

AJX (ASX) Chart

Ann: Foundation for 2016, page-195

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Zeta Resources seeks to resolve the Panoramic takeover story

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Foundation for 2016, page-195

Top Stories

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Zeta Resources seeks to resolve the Panoramic takeover story

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News